<?xml version="1.0" encoding="UTF-8"?>
<p>An infectious agent belonging to coronavirus genus, severe acute respiratory syndrome-associated coronavirus (SARS-CoV) [
 <xref rid="B33-pharmaceuticals-14-00381" ref-type="bibr">33</xref>], caused more than 750 deaths distributed in 26 countries in late 2002 and the first half of 2003. In total there were more than 8000 cases of people infected with this virus, with a fatality rate of 9.6%. People who contracted SARS had symptoms such as fever, cough and dyspnoea, while common serological tests recorded lymphopenia, thrombocytopenia and C-reactive protein [
 <xref rid="B34-pharmaceuticals-14-00381" ref-type="bibr">34</xref>]. From a histopathological point of view, patients with full-blown SARS disease, have also reported serious problems in lungs, recording significant alveolar damage, which led the patient to develop pneumonia [
 <xref rid="B35-pharmaceuticals-14-00381" ref-type="bibr">35</xref>]. Some studies showed that this virus could originate from animals, by means of an interspecies transmission [
 <xref rid="B36-pharmaceuticals-14-00381" ref-type="bibr">36</xref>,
 <xref rid="B37-pharmaceuticals-14-00381" ref-type="bibr">37</xref>]
</p>
